| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987119 Pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them and anticancer agents |
| 01/17/2006 | US6987118 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2300069C Naphthalimidobenzamide derivatives |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/12/2006 | WO2006004925A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2006004533A1 Compounds |
| 01/12/2006 | WO2006004532A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases |
| 01/12/2006 | WO2006003946A1 Process for production of benzimidazole derivative salt precipitates |
| 01/12/2006 | WO2006003494A2 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides |
| 01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | WO2006003163A1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation |
| 01/12/2006 | WO2006003150A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006003148A1 Quinazolinedione derivatives as parp inhibitors |
| 01/12/2006 | WO2006003146A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006002956A1 Piperidine derivatives and their use as glycine transporter inhibitors |
| 01/12/2006 | WO2006002875A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002874A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002873A2 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
| 01/12/2006 | WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases |
| 01/12/2006 | WO2005105079A3 Novel imidazoles |
| 01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | WO2005080343A3 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
| 01/12/2006 | WO2005077902A3 Methods for the synthesis of pyridoxamine |
| 01/12/2006 | WO2005060959A8 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009487 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
| 01/12/2006 | US20060009475 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009472 Substituted imidazole derivatives |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009460 e.g. N-(4-(4-methylpiperazin-1-yl)phenyl)-6-phenylquinolin-4-amine;protein kinase A, C, G, tyrosine kinase, mitogen activated p38- alpha kinase inhibitor; tumor necrosis factor- alpha and interleukin-1 beta antagonist; antiinflammatory, anticarcinogenic; Alzheimer's disease, stroke, diabetes, obesity |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | DE102004031100A1 Anthranilamide Anthranilamides |
| 01/12/2006 | DE102004030502A1 Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel New imidazoles and triazoles, their preparation and use as medicaments |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572075A1 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2569827A1 Quinazolinedione derivatives as parp inhibitors |
| 01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2569824A1 Phthalazine derivatives as parp inhibitors |
| 01/12/2006 | CA2569727A1 Compounds |
| 01/12/2006 | CA2569716A1 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2568808A1 Chemical compounds |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613621A1 Prostaglandin analogs as ep4 receptor agonists |
| 01/11/2006 | EP1613617A2 Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613616A2 Process for making substituted pyrazoles |
| 01/11/2006 | EP1613615A2 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613614A2 Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613613A2 Cxcr4 chemokine receptor binding compounds |
| 01/11/2006 | EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 01/11/2006 | EP1613601A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 01/11/2006 | EP1613600A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613595A2 Novel compounds and compositions as protein kinase inhibitors |
| 01/11/2006 | EP1613592A2 Hydroxamic acid compounds and methods of use thereof |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613322A2 Aminoquinoline compounds |
| 01/11/2006 | EP1613315A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 01/11/2006 | EP1613312A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613310A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 01/11/2006 | EP1613305A1 Crystalline n-formyl hydroxylamine compounds |
| 01/11/2006 | EP1613304A1 Dpp-iv inhibitors |
| 01/11/2006 | EP1613265A2 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613156A1 N-phenyl- " (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 01/11/2006 | EP1442035B1 Process for the preparation of 4- (8-chloro-5, 6-dihydro-11h-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
| 01/11/2006 | EP1340753B1 Carbamate derivatives, process for producing the same and use thereof |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
| 01/11/2006 | CN1720245A Oxime ester photoinitiators with heteroaromatic groups |
| 01/11/2006 | CN1720244A Anthranilic acid amide derivatives and their pharmaceutical use |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |